Telemedicine for recovering COVID-19 patients
- Conditions
- 10047438COVID-1910024970
- Registration Number
- NL-OMON49189
- Lead Sponsor
- niversitair Medisch Centrum Utrecht
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
- The patient is admitted to the hospital with COVID-19 pneumonia;
- The patient is recovering;
- The patient is expected to be discharged home;
- A partner/primary caregiver is available at the patients home for support;
- A rectal thermometer is available;
- The patient is in possession of a smartphone with the ability to host the
Luscii app (iOS or Android);
- The patient or the caregiver is able to use the smartphone and Luscii app;
- The patient or the caregiver is able to use the pulse oximeter;
- The patient or the caregiver is able to speak, read and understand the Dutch
language sufficiently enough to be able to use the Luscii app;
- A patient with dementia or severe psychiatric disorder who is unlikely to be
compliant to the intervention (to be determined by treating physician);
- A patient who is discharged to a care facility or rehabilitation center;
- A patient who needs more medical support than the caregivers or CaHS can
manage.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary endpoint is the difference in number of days alive at home, 30 days<br /><br>from randomization. </p><br>
- Secondary Outcome Measures
Name Time Method <p>Secondary endpoints are the difference in mortality, hospital length of stay,<br /><br>readmission to the hospital and to the ICU, number of unplanned visits to the<br /><br>hospital and number of visits to the general practitioner, and Hospital Anxiety<br /><br>and Depression Scale score after randomization and at discharge. </p><br>